These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18098000)

  • 1. The application of machine learning techniques as an adjunct to clinical decision making in alcohol dependence treatment.
    Connor JP; Symons M; Feeney GF; Young RM; Wiles J
    Subst Use Misuse; 2007; 42(14):2193-206. PubMed ID: 18098000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic configuration: a model for an integrated approach to the understanding of disease.
    Margaron H
    Subst Use Misuse; 2007; 42(14):2183-92. PubMed ID: 18097999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
    Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
    Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is acamprosate use in alcohol dependence treatment reflected in improved subjective health status outcomes beyond cognitive behavioural therapy alone?
    Feeney GF; Connor JP; McD Young R; Tucker J; McPherson A
    J Addict Dis; 2006; 25(4):49-58. PubMed ID: 17088225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved?
    Feeney GF; Young RM; Connor JP; Tucker J; McPherson A
    Aust N Z J Psychiatry; 2002 Oct; 36(5):622-8. PubMed ID: 12225445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients.
    Weinstein A; Feldtkeller B; Feeney A; Lingford-Hughes A; Nutt D
    Addict Biol; 2003 Jun; 8(2):229-32. PubMed ID: 12850782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical predictors of outcome from an Australian pharmacological relapse prevention trial.
    Morley KC; Teesson M; Sannibale C; Baillie A; Haber PS
    Alcohol Alcohol; 2010; 45(6):520-6. PubMed ID: 20952764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care.
    Kiritzé-Topor P; Huas D; Rosenzweig C; Comte S; Paille F; Lehert P
    Alcohol Alcohol; 2004; 39(6):520-7. PubMed ID: 15304381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.
    Mason BJ
    J Clin Psychiatry; 2001; 62 Suppl 20():42-8. PubMed ID: 11584875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients.
    Diehl A; Ulmer L; Mutschler J; Herre H; Krumm B; Croissant B; Mann K; Kiefer F
    Alcohol Alcohol; 2010; 45(3):271-7. PubMed ID: 20348436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction.
    Pelc I; Ansoms C; Lehert P; Fischer F; Fuchs WJ; Landron F; Pires Preto AJ; Morgan MY
    Alcohol Clin Exp Res; 2002 Oct; 26(10):1529-38. PubMed ID: 12394286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological relapse prevention of alcoholism: clinical predictors of outcome.
    Kiefer F; Helwig H; Tarnaske T; Otte C; Jahn H; Wiedemann K
    Eur Addict Res; 2005; 11(2):83-91. PubMed ID: 15785069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of acamprosate in the treatment of alcohol dependence.
    Cayley WE
    Am Fam Physician; 2011 Mar; 83(5):522-4. PubMed ID: 21391519
    [No Abstract]   [Full Text] [Related]  

  • 17. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
    Rösner S; Leucht S; Lehert P; Soyka M
    J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
    Baser O; Chalk M; Rawson R; Gastfriend DR
    Am J Manag Care; 2011 Jun; 17 Suppl 8():S222-34. PubMed ID: 21761948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.
    Mason BJ; Goodman AM; Chabac S; Lehert P
    J Psychiatr Res; 2006 Aug; 40(5):383-93. PubMed ID: 16546214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of acamprosate on alcohol and food craving in patients with alcohol dependence.
    Han DH; Lyool IK; Sung YH; Lee SH; Renshaw PF
    Drug Alcohol Depend; 2008 Mar; 93(3):279-83. PubMed ID: 17983709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.